A PHARMACOKINETIC STUDY OF ORAL PACLITAXEL IN COMBINATION WITH HM30181 IN SOLID CANCER PATIENTS

被引：0
|
作者：
Kim, S. E. [1 ]
Gu, N. [1 ]
Shin, D. [1 ]
Yoon, S. H. [1 ]
Cho, J. Y. [1 ]
Shin, S. G. [1 ]
Yu, K. S. [1 ]
Jang, I. J. [1 ]
机构：
[1] Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] An open-label, randomized cross-over bioavailability study of oral paclitaxel and HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours
    Jackson, C. G. C. A.
    Deva, S.
    Bayston, K.
    Barlow, P.
    Eden, K.
    Hung, N.
    Fetterly, G.
    Cutler, D.
    Kwan, R.
    Kramer, D.
    Chan, W-K
    Hung, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] An open-label, randomized cross-over bioavailability and extension study of oral paclitaxel and HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours.
    Jackson, Christopher G. C. A.
    Deva, Sanjeev
    Bayston, Katherine Francis
    Eden, Karen
    McLaren, Blair Richard
    Barlow, Paula
    Hung, Noelyn Anne
    Clarke, Kate
    Cutler, David
    Fetterly, Gerald
    Kwan, Min-Fun Rudolf
    Kramer, Douglas
    Chan, Wing Kai
    Hung, Tak
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel
    Kwak, Jin-Oh
    Lee, Sung Hee
    Lee, Gwan Sun
    Kim, Maeng Sup
    Ahn, Young-Gil
    Lee, Ji Hyun
    Kim, So Won
    Kim, Kyung Hwan
    Lee, Min Goo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 92 - 98
  • [4] Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor
    Kim, Jin Cheul
    Kim, Kyeong Soo
    Kim, Dong Shik
    Jin, Sung Giu
    Kim, Dong Wuk
    Kim, Yong Il
    Park, Jae-Hyun
    Kim, Jong Oh
    Yong, Chul Soon
    Youn, Yu Seok
    Woo, Jong Soo
    Choi, Han-Gon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 506 (1-2) : 93 - 101
  • [5] Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients
    Dai, M-S.
    Chao, T-Y.
    Chao, T-C.
    Chiu, C-F.
    Lu, Y-S.
    Shiah, H-S.
    Wu, Y-Y.
    Fetterly, G. Gerald
    Hung, N.
    Cutler, D. L.
    Kwan, R.
    Kramer, D. Douglas
    Chan, W-K.
    Hung, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies
    Villalona-Calero, MA
    Weiss, GR
    Burris, HA
    Kraynak, M
    Rodrigues, G
    Drengler, RL
    Eckhardt, SG
    Reigner, B
    Moczygemba, J
    Burger, HU
    Griffin, T
    Von Hoff, DD
    Rowinsky, EK
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1915 - 1925
  • [7] An international randomized cross-over bio-equivalence study of oral paclitaxel+HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours
    Jackson, C. G. C. A.
    Deva, S.
    Bayston, K.
    McLaren, B.
    Barlow, P.
    Hung, N. A.
    Clarke, K.
    Segelov, E.
    Chao, T. -Y.
    Dai, M. -S.
    Yen, H. -T.
    Cutler, D.
    Kramer, D.
    Zhi, J.
    Chan, W. -K.
    Kwan, M. -F. R.
    Hung, C. -T.
    ANNALS OF ONCOLOGY, 2019, 30 : 180 - +
  • [8] A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HIVI30181A, in Patients with Advanced Solid Cancer
    Lee, Hyun Jung
    Heo, Dae-Seog
    Cho, Joo-Youn
    Han, Sae-Won
    Chang, Hye-Jung
    Yi, Hyeon-Gyu
    Kim, Tae-Eun
    Lee, Se-Hoon
    Oh, Do-Youn
    Im, Seock-Ah
    Jang, In-Jin
    Bang, Yung-Jue
    CANCER RESEARCH AND TREATMENT, 2014, 46 (03): : 234 - 242
  • [9] Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants
    Cha, Yu-Jung
    Lee, Howard
    Gu, Namyi
    Kim, Tae-Eun
    Lim, Kyoung S.
    Yoon, Seo H.
    Chung, Jae-Yong
    Jang, In-Jin
    Shin, Sang-Goo
    Yu, Kyung-Sang
    Cho, Joo-Youn
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (06) : 419 - 424
  • [10] HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)
    Koehler, Sebastian C.
    Wiese, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (09) : 3910 - 3921
12345